Increasing Demand for Aliskiren in the Pharmaceutical Sector to Fuel the 3-amino-2,2-dimethylpropionamide Market


Posted March 7, 2019 by sakshiTMR

Increasing Demand for Aliskiren in the Pharmaceutical Sector to Fuel the 3-amino-2,2-dimethylpropionamide Market

 
Transparency Market Research in its new report titled, “3-amino-2,2-dimethylpropionamide Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2018 – 2026,” provides key insights on the 3-amino-2,2-dimethylpropionamide market. The TMR report anticipates that the increasing demand for aliskiren in the pharmaceutical sector will drive the 3-amino-2,2-dimethylpropionamide market during the forecast period i.e, 2018-2026. The demand for 3-amino-2,2-dimethylpropionamide is anticipated to increase significantly in the near future, primarily due to the rising demand for antihypertensive drugs. Aliskiren has been approved for use in the treatment of chronic kidney disease (CKD) and hypertension, says the report.
As per the report, there is also a possibility of Aliskiren becoming a reasonable therapeutic choice for numerous clinical conditions such as diabetes, cerebrovascular disease, cardiorenal syndrome, stable coronary artery disease, and peripheral arterial disease in the next few years. This is anticipated to increase the demand for Aliskiren in the near future, thereby driving the market for 3-amino-2,2-dimethylpropionamide. Furthermore, the pharmaceutical industry has witnessed rapid growth in the last few years. The trend is expected to continue throughout the forecast period, thereby propelling the demand for 3-amino-2,2-dimethylpropionamide. The report has split the global 3-amino-2,2-dimethylpropionamide market based on purity, application, and region. In accordance with purity, the global 3-amino-2,2-dimethylpropionamide market is classified into less than 99% pure and more than 99% pure. In terms of application, the market is divided into R&D, reagents for pharmaceutical drugs, and others.
From a regional perspective, the global 3-amino-2,2-dimethylpropionamide market is divided into North America, Asia Pacific, Latin America, Europe, and Middle East & Africa. In terms of consumption, North America dominated the global 3-amino-2,2-dimethylpropionamide market in 2017, closely followed by Europe and Asia Pacific. The region is expected to dominate the global market throughout the forecast period. This can be primarily ascribed to growth of the pharmaceutical industry in the region, particularly in the U.S. The pharmaceutical industry in North America is the largest continental pharmaceutical industry worldwide. The U.S. alone accounts for over 45% share of the global pharmaceutical industry.
On the other hand, in terms of production, Asia Pacific dominates the global 3-amino-2,2-dimethylpropionamide market. The market in Asia Pacific is anticipated to be expand at a rapid pace in the next few years. The region is likely to offer substantial growth opportunities to the market in the near future. Furthermore, India, Japan, Singapore, South Korea, Australia, and countries in Southeast Asia are anticipated to offer immense growth opportunities to the 3-amino-2,2-dimethylpropionamide market in Asia Pacific during the forecast period, owing to growth of the pharmaceutical sector in these countries. The markets in Latin America and Middle East & Africa are also anticipated to expand at high growth rates in the near future.
Leading companies operating in the global 3-amino-2,2-dimethylpropionamide market are profiled in this report to give a better competitive analysis and these include BASF AG, Yangzhou Princechem Co., Ltd., Zhejiang Tianyu Pharmaceutical Co., Ltd., Hangzhou Coben Pharmaceutical Co., Ltd., Dishman USA, Inc., Clearsynth Canada INC, Jinan Finer Chemical Co., Ltd., LUNA Chemicals Co., Ltd., Ark Pharm, Inc., Shanghai Yuanye Bio-Technology Co., Ltd., BrightGene Bio-medical Technology Co., Ltd., Advanced ChemBlocks Inc., Nanjing Ange Pharmaceutical Co., Ltd., Toronto Research Chemicals Inc., and Matrix Scientific.
About Us
Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Email: [email protected]
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Transparency Market Research
Phone 5186181030
Business Address 90 State Street, Suite 700 Albany, NY 12207
Country United States
Categories Biotech , Research , Science
Tags 3amino2 , 2dimethylpropionamide , 2dimethylpropionamide market , 2dimethylpropionamide market size
Last Updated March 7, 2019